Creating Innovative Cancer Immunotherapies by Leveraging Underexploited Biological Opportunities April 2019 NYSE: RCUS Forward-Looking Statements/Safe Harbor This presentation contains forward-looking statements about Arcus Biosciences, Inc. ("we," "Arcus" or the "Company") made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this presentation are forward-looking statements, including statem ...